General Information
Version
8.2
Revision date
2025-05-26
Product name
Vinorelbine Tartrate
CAS No.
125317-39-7
REACH No
A
Emergency telephone
+56 2 2581 4934
Icons in SDS
Company Information
company name
Merck S.A
e-mail address of the competent person responsible for the Safety Data Sheet
atencionclientes@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H300, H341, H351, H360D, H372
Hazard statements
Code
Statements
H300
Fatal if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture Acute toxicity, (Category 2) H300: Fatal if swallowed Germ cell mutagenicity, H341: Suspected of causing genetic Category 2) defects Carcinogenicity, (Category 2) H351: Suspected of causing cancer Reproductive toxicity, (Category H360D: May damage the unborn child 1B) Specific target organ toxicity - H372: Causes damage to organs through repeated exposure, (Category 1) prolonged or repeated exposure
Signal word
Danger
Hazard statements
H300 Fatal if swallowed. H341 Suspected of causing genetic defects. H351 Suspected of causing cancer. H360D May damage the unborn child. H372 Causes damage to organs through prolonged or repeated exposure.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER/ doctor.
Supplemental label elements
none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Acute toxicity, (Category 2) H300: Fatal if swallowed. Germ cell mutagenicity, H341: Suspected of causing genetic (Category 2) defects. Carcinogenicity, (Category 2) H351: Suspected of causing cancer. Reproductive toxicity, (Category H360D: May damage the unborn child. 1B) Specific target organ toxicity - H372: Causes damage to organs through repeated exposure, (Category 1) prolonged or repeated exposure.